CMIC Group, the first and leading CRO in Japan with end-to-end solutions, will exhibit at TIDES: Oligonucleotide and Peptide Therapeutics.
Our bioanalytical lab, CMIC, INC. (Illinois, U.S.), is a leading company in the field of oligonucleotide bioanalysis services in the U.S. We will introduce our capability and solutions that support our clients’ various needs.